(Q45714051)

English

Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort

scientific article published in April 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hubert G.M. Niesters

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Wolters LM

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

van der Ende ME

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Kroon FP

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Richter C

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Brinkman K

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Meenhorst PL

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

de Man RA

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Journal of Clinical Virology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

173-181

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine treatment for acute hepatitis B after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance testing of clinical data using virus dynamics models with a Markov chain Monte Carlo method: application to emergence of lamivudine-resistant hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine resistance inimmunocompetent chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and complications in a cohort of patients with anti-Delta positive liver disease presenting in a tertiary referral clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study. CAESAR co-ordinating committee

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Coinfection and superinfection of hepatitis B virus in patients infected with human immunodeficiency virus: no evidence of faster progression to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900245-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1386-6532(01)00245-1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45714051&oldid=2077709756"